Literature DB >> 7042430

Effect of acute hyperglycaemia on plasma potassium and aldosterone levels in type 2 (non-insulin-dependent) diabetes.

J Rosenstock, S A Loizou, I E Brajkovich, K Mashiter, G F Joplin.   

Abstract

Potassium homeostasis during a 50-g oral glucose tolerance test was studied in 14 newly diagnosed, untreated Type 2 (non-insulin-dependent) diabetics. They showed a rise in plasma potassium from a mean +/- SEM basal of 3.9 +/- 0.1 to 4.4 +/- 0.1 mmol/l at 60 min and to 4.6 +/- 0.1 mmol/l at 90 min (p less than 0.01), whereas no change was seen in a group of 14 normal subjects. A possible role of mineralocorticoids was sought by measuring simultaneous serum aldosterone and deoxycorticosterone levels. Aldosterone was reduced after the glucose load in all subjects studied, falling to 73% of basal at 60 min in diabetics (p less than 0.01), and to 61% of basal at 90 min in normal subjects (p less than 0.001). Serum deoxycorticosterone showed a similar pattern. Thus it is unlikely that the rise in plasma potassium seen in the diabetic patients was due to abnormal levels of mineralocorticoids. Since the diabetic subjects were found to have an intact insulin response to the glucose load, it is suggested that resistance to insulin-stimulated potassium uptake into cells might be involved in the pathogenesis of the paradoxical hyperkalaemia induced by acute hyperglycaemia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042430     DOI: 10.1007/bf00283750

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  21 in total

1.  Effect of insulin on carbohydrate metabolism and on potassium in the forearm of man.

Authors:  R ANDRES; M A BALTZAN; G CADER; K L ZIERLER
Journal:  J Clin Invest       Date:  1962-01       Impact factor: 14.808

2.  Simplification of urinary aldosterone measurement by radioimmunoassay.

Authors:  C L Cope; S Loizou
Journal:  J Clin Pathol       Date:  1973-08       Impact factor: 3.411

3.  Necessity for insulin in transfer of excess infused K to intracellular fluid.

Authors:  N Hiatt; T Yamakawa; M B Davidson
Journal:  Metabolism       Date:  1974-01       Impact factor: 8.694

4.  Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man.

Authors:  R A DeFronzo; P Felig; E Ferrannini; J Wahren
Journal:  Am J Physiol       Date:  1980-05

5.  Effect of osmolarity on intracellular pH of rat diaphragm muscle.?22.

Authors:  S Adler; B Anderson; B Zett
Journal:  Am J Physiol       Date:  1975-03

6.  Potassium homeostasis in chronic diabetes mellitus.

Authors:  G O Perez; L Lespier; R Knowles; J R Oster; C A Vaamonde
Journal:  Arch Intern Med       Date:  1977-08

7.  Radioimmunoassays for aldosterone and deoxycorticosterone in plasma and urine.

Authors:  A B Kurtz; F C Bartter
Journal:  Steroids       Date:  1976-07       Impact factor: 2.668

8.  Nonketotic diabetes mellitus: insulin deficiency or insulin resistance?

Authors:  G M Reaven; R Bernstein; B Davis; J M Olefsky
Journal:  Am J Med       Date:  1976-01       Impact factor: 4.965

9.  Comparison of the effectiveness of various routes of insulin injection: insulin levels and glucose response in normal subjects.

Authors:  S M Guerra; A E Kitabchi
Journal:  J Clin Endocrinol Metab       Date:  1976-05       Impact factor: 5.958

10.  Glucose-induced hyperkalaemia: A hazard for diabetics?

Authors:  G C Viberti
Journal:  Lancet       Date:  1978-04-01       Impact factor: 79.321

View more
  7 in total

Review 1.  Fortnightly review: Beneficial effects of potassium.

Authors:  F J He; G A MacGregor
Journal:  BMJ       Date:  2001-09-01

2.  Genetic variation in aldosterone synthase predicts plasma glucose levels.

Authors:  K Ranade; K D Wu; N Risch; M Olivier; D Pei; C F Hsiao; L M Chuang; L T Ho; E Jorgenson; R Pesich; Y D Chen; V Dzau; A Lin; R A Olshen; D Curb; D R Cox; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

Review 3.  Hypertension and diabetes. Clinical problems.

Authors:  M T Zanella; R C Santiago; J R de Sá; B J Salgado; S F de Faria; R B Peres; O Kohlmann Júnior; A B Ribeiro
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Angiotensin-converting enzyme (ACE) inhibition. Therapeutic option for diabetic hypertensive patients.

Authors:  M T Zanella; B J Salgado; O Kohlmann; A B Ribeiro
Journal:  Drugs       Date:  1990       Impact factor: 9.546

5.  Hyperkalaemia in diabetes: prevalence and associations.

Authors:  P R Jarman; A M Kehely; H M Mather
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

6.  Hyperkalaemia in diabetes mellitus--potential hazards of coexisting hyporeninaemic hypoaldosteronism.

Authors:  D M Large; P H Carr; I Laing; M Davies
Journal:  Postgrad Med J       Date:  1984-05       Impact factor: 2.401

7.  Serum potassium concentration in hyperglycemia of diabetes mellitus with long-term dialysis.

Authors:  A H Tzamaloukas; P S Avasthi
Journal:  West J Med       Date:  1987-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.